Business Description
EP Biocomposites Ltd
ISIN : INE0D2I01014
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 1.9 | |||||
Interest Coverage | 8.7 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.47 | |||||
Beneish M-Score | -1.29 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 57.1 | |||||
3-Year EBITDA Growth Rate | 54.3 | |||||
3-Year EPS without NRI Growth Rate | 46.7 | |||||
3-Year Book Growth Rate | 191.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.87 | |||||
9-Day RSI | 49.58 | |||||
14-Day RSI | 49.43 | |||||
3-1 Month Momentum % | 7.4 | |||||
6-1 Month Momentum % | 16.67 | |||||
12-1 Month Momentum % | -6.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.89 | |||||
Quick Ratio | 2.58 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 58.89 | |||||
Days Sales Outstanding | 188.7 | |||||
Days Payable | 106.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.35 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.97 | |||||
Operating Margin % | 14.57 | |||||
Net Margin % | 9.91 | |||||
FCF Margin % | -24.27 | |||||
ROE % | 12.16 | |||||
ROA % | 8.09 | |||||
ROIC % | 11.3 | |||||
3-Year ROIIC % | 6.85 | |||||
ROC (Joel Greenblatt) % | 33.65 | |||||
ROCE % | 16.86 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.17 | |||||
PE Ratio without NRI | 24.17 | |||||
PS Ratio | 2.4 | |||||
PB Ratio | 2.81 | |||||
Price-to-Tangible-Book | 2.83 | |||||
EV-to-EBIT | 16.7 | |||||
EV-to-EBITDA | 15.73 | |||||
EV-to-Revenue | 2.59 | |||||
EV-to-FCF | -10.68 | |||||
Price-to-Graham-Number | 1.74 | |||||
Price-to-Net-Current-Asset-Value | 3.8 | |||||
Earnings Yield (Greenblatt) % | 5.99 | |||||
FCF Yield % | -10.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Ā
Total Annual Return % Ā
EP Biocomposites Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ā¹) | 114.455 | ||
EPS (TTM) (ā¹) | 6.741 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 45.28 | ||
14-Day RSI | 49.43 | ||
14-Day ATR (ā¹) | 10.137117 | ||
20-Day SMA (ā¹) | 156.21 | ||
12-1 Month Momentum % | -6.54 | ||
52-Week Range (ā¹) | 122 - 218 | ||
Shares Outstanding (Mil) | 1.68 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EP Biocomposites Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EP Biocomposites Ltd Stock Events
Event | Date | Price (ā¹) | ||
---|---|---|---|---|
No Event Data |
EP Biocomposites Ltd Frequently Asked Questions
What is EP Biocomposites Ltd(BOM:543595)'s stock price today?
When is next earnings date of EP Biocomposites Ltd(BOM:543595)?
Does EP Biocomposites Ltd(BOM:543595) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |